Acino Rus joined the ACHI.

Acino Rus became a member of the Association of Consumer Health Industry. The decision was approved by the General Meeting of the Association members in May 2023.

Acino Rus is the Russian division of the international pharmaceutical group Acino headquartered in Zurich, Switzerland. The company's portfolio includes prescription and non-prescription drugs and dietary supplements in therapeutic areas such as women's health, proctology, urology. The dynamically developing activity of Acino Rus is based on high quality products and commitment to patient care.

“We are pleased to welcome Acino Rus as a member of our Association. The professional community of manufacturers of consumer health products is strengthening and expanding despite the rapidly changing external conditions and the challenges we face,” says Elena Nevolina, Executive Director of ACHI. “We look forward to many years of fruitful cooperation with the Acino Rus team in order to promote the concept of a responsible self-care in Russia and promote the development of the consumer health products industry in the interests of consumers and patients.”

Denis Glyadyaev, General Director of Acino Rus, notes: “Now for patients and the industry as a whole, it is especially important to maintain islands of stability. This concerns the availability of drugs on the market, as well as maintaining the further course of pharmaceutical players to develop the industry with a focus on patients and consumers. For our company, the opportunity to join and supplement the professional community of manufacturers as part of the Association is just the opportunity to unite and increase common efforts.”

Andrey Dorofeev, Strategy Director at Acino Rus comments: “The Acino Rus team is delighted to become a member of the Association of Consumer Health Industry and looks forward to a long-term, fruitful cooperation. We are confident that the joint efforts of the members of the Association will make a significant contribution to improving the quality of life of patients.”